Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer, Urothelial Cancer

Neeraj Agarwal

MD

🏢Huntsman Cancer Institute, University of Utah🌐USA

Professor of Medicine and Director of Genitourinary Oncology

64
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Neeraj Agarwal is a prominent clinical investigator in genitourinary oncology who has contributed to multiple landmark trials in prostate and urothelial cancers. His research has focused on mechanisms of resistance to hormonal therapies in prostate cancer and how treatment sequencing affects outcomes. He has led studies of abiraterone, enzalutamide, and novel AR pathway inhibitors in metastatic prostate cancer. His translational work examines how genomic features predict response and resistance to endocrine therapies.

Share:

🧪Research Fields 研究领域

prostate cancer hormonal therapy
urothelial cancer EV
cabazitaxel
abiraterone resistance
androgen deprivation sequencing

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Neeraj Agarwal 的研究动态

Follow Neeraj Agarwal's research updates

留下邮箱,当我们发布与 Neeraj Agarwal(Huntsman Cancer Institute, University of Utah)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment